(R)-2-Amino-2-(3-bromophenyl)aceticacid
97%
- Product Code: 232031
CAS:
2166163-71-7
| Molecular Weight: | 230.06 g./mol | Molecular Formula: | C₈H₈BrNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature |
Product Description:
Used in the synthesis of pharmaceutical intermediates, particularly in the development of central nervous system agents. Its chiral structure makes it valuable in asymmetric synthesis for producing enantiomerically pure drugs. Commonly employed in the preparation of anticonvulsant and anxiolytic compounds due to the bromophenyl moiety’s influence on biological activity. Also utilized in research for designing enzyme inhibitors and receptor ligands where stereochemistry plays a critical role in efficacy.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿8,500.00 |
+
-
|
| 250mg | 10-20 days | ฿14,410.00 |
+
-
|
| 1g | 10-20 days | ฿32,320.00 |
+
-
|
(R)-2-Amino-2-(3-bromophenyl)aceticacid
Used in the synthesis of pharmaceutical intermediates, particularly in the development of central nervous system agents. Its chiral structure makes it valuable in asymmetric synthesis for producing enantiomerically pure drugs. Commonly employed in the preparation of anticonvulsant and anxiolytic compounds due to the bromophenyl moiety’s influence on biological activity. Also utilized in research for designing enzyme inhibitors and receptor ligands where stereochemistry plays a critical role in efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :